SHP2 acts both upstream and downstream of multiple receptor tyrosine kinases to promote basal-like and triple-negative breast cancer
Crossref DOI link: https://doi.org/10.1186/s13058-015-0659-z
Published Online: 2016-01-04
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Matalkah, Fatimah
Martin, Elisha
Zhao, Hua
Agazie, Yehenew M.
Funding for this research was provided by:
National Institutes of Health (CA124940)
Text and Data Mining valid from 2016-01-04
Version of Record valid from 2016-01-04
Article History
Received: 27 October 2015
Accepted: 25 November 2015
First Online: 4 January 2016